Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119


Healthcare worker perceived barriers to early initiation of antiretroviral and tuberculosis therapy among Tanzanian inpatients.

Wajanga BM, Peck RN, Kalluvya S, Fitzgerald DW, Smart LR, Downs JA.

PLoS One. 2014 Feb 14;9(2):e87584. doi: 10.1371/journal.pone.0087584.


Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines.

Choun K, Pe R, Thai S, Lorent N, Lynen L, van Griensven J.

Bull World Health Organ. 2013 Mar 1;91(3):195-206. doi: 10.2471/BLT.12.111153.


Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.

Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, Meintjes G.

PLoS One. 2011 May 12;6(5):e19484. doi: 10.1371/journal.pone.0019484.


Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy.

Kredo T, Adeniyi FB, Bateganya M, Pienaar ED.

Cochrane Database Syst Rev. 2014 Jul 1;(7):CD007331. doi: 10.1002/14651858.CD007331.pub3. Review.


Highly active antiretroviral therapy for patients with tuberculosis: the solution or the problem?

Boix V, Merino E, Portilla J.

AIDS. 2002 Jul 5;16(10):1436-7. No abstract available.


Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G.

JAMA. 2008 Aug 6;300(5):530-9. doi: 10.1001/jama.300.5.530.


Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.

Kumar A, Kumar AM, Gupta D, Kanchar A, Mohammed S, Srinath S, Tripathy S, Rajasekaran S, Chan PL, Swaminathan S, Dewan PK.

Int J Tuberc Lung Dis. 2012 May;16(5):573-8. doi: 10.5588/ijtld.11.0482.


Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial.

Fielding KL, Charalambous S, Hoffmann CJ, Johnson S, Tlali M, Dorman SE, Vassall A, Churchyard GJ, Grant AD.

Trials. 2015 Mar 28;16:125. doi: 10.1186/s13063-015-0650-0.


Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi.

Kumwenda M, Tom S, Chan AK, Mwinjiwa E, Sodhi S, Joshua M, van Lettow M.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1663-9. doi: 10.5588/ijtld.10.0741.


Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.

Lawn SD, Ayles H, Egwaga S, Williams B, Mukadi YD, Santos Filho ED, Godfrey-Faussett P, Granich RM, Harries AD.

Int J Tuberc Lung Dis. 2011 Mar;15(3):287-95.


Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales.

Kipp AM, Pungrassami P, Stewart PW, Chongsuvivatwong V, Strauss RP, Van Rie A.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1540-5, i. doi: 10.5588/ijtld.10.0273.


Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa.

Lawn SD, Campbell L, Kaplan R, Boulle A, Cornell M, Kerschberger B, Morrow C, Little F, Egger M, Wood R; International Epidemiological Databases to Evaluate AIDS-Southern Africa..

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):136-40. doi: 10.1097/QAI.0b013e3182199ee9.


Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.

Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Nyirenda M, Naidoo K, Hakim J, Mugyenyi P, Henostroza G, Leger PD, Lama JR, Mohapi L, Alave J, Mave V, Veloso VG, Pillay S, Kumarasamy N, Bao J, Hogg E, Jones L, Zolopa A, Kumwenda J, Gupta A; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team..

Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8.


Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi.

Tweya H, Ben-Smith A, Kalulu M, Jahn A, Ng'ambi W, Mkandawire E, Gabriel L, Phiri S.

BMC Public Health. 2014 Feb 20;14:183. doi: 10.1186/1471-2458-14-183.


Antiretroviral therapy and TB.

Swaminathan S, Luetkemeyer A, Srikantiah P, Lin R, Charlebois E, Havlir DV.

Trop Doct. 2006 Apr;36(2):73-9. Review.


Early lessons from the integration of tuberculosis and HIV services in primary care centers in Lusaka, Zambia.

Harris JB, Hatwiinda SM, Randels KM, Chi BH, Kancheya NG, Jham MA, Samungole KV, Tambatamba BC, Cantrell RA, Levy JW, Kimerling ME, Reid SE.

Int J Tuberc Lung Dis. 2008 Jul;12(7):773-9.


Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.

Manosuthi W, Tantanathip P, Chimsuntorn S, Eampokarap B, Thongyen S, Nilkamhang S, Sungkanuparph S.

Int J Infect Dis. 2010 Nov;14(11):e1013-7. doi: 10.1016/j.ijid.2010.06.016.


Treatment Options for HIV-Associated Tuberculosis.

Onyebujoh PC, Ribeiro I, Whalen CC.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S35-45. Review.


[Practice guideline prevention, diagnosis and treatment of tuberculosis in patients with an HIV infection].

van Leth F, Gebhart AC, van Altena R, Rijkeboer AA, Reusken AM, van Gerven PJ; Werkgroup TB-HIV van de Commissie voor Praktische Tuberculosebestrijding..

Ned Tijdschr Geneeskd. 2009;153:A1225. Dutch.


Factors influencing uptake of HIV care and treatment among children in South Africa - a qualitative study of caregivers and clinic staff.

Yeap AD, Hamilton R, Charalambous S, Dwadwa T, Churchyard GJ, Geissler PW, Grant AD.

AIDS Care. 2010 Sep;22(9):1101-7. doi: 10.1080/09540121003602218.

Items per page

Supplemental Content

Support Center